Cancer Angiogenesis Induced by Kaposi Sarcoma-associated Herpesvirus is Mediated by EZH2

Overview

Journal Cancer Res

Specialty Oncology

Date 2012 May 18

PMID 22593192

Citations 41

Authors

Meilan He

Wei Zhang

Thomas Bakken

Melissa Schutten

Zsolt Toth

Jae U Jung

Parkash Gill

Mark Cannon

Shou-Jiang Gao

Affiliations

Soon will be listed here.

Abstract

EZH2 is a component of the epigenetic regulator PRC2 that suppresses gene expression. Elevated expression of EZH2 is common in human cancers and is associated with tumor progression and poor prognosis. In this study, we show that EZH2 elevation is associated with epigenetic modifications of Kaposi sarcoma-associated herpesvirus (KSHV), an oncogenic virus that promotes the development of Kaposi sarcoma and other malignancies that occur in patients with chronic HIV infections. KSHV induction of EZH2 expression was essential for KSHV-induced angiogenesis. High expression of EZH2 was observed in Kaposi sarcoma tumors. In cell culture, latent KSHV infection upregulated the expression of EZH2 in human endothelial cells through the expression of vFLIP and LANA, two KSHV-latent genes that activate the NF-κB pathway. KSHV-mediated upregulation of EZH2 was required for the induction of Ephrin-B2, an essential proangiogenic factor that drives endothelial cell tubule formation. Taken together, our findings indicate that KSHV regulates the host epigenetic modifier EZH2 to promote angiogenesis.

Citing Articles

Epigenetic and epitranscriptomic regulation during oncogenic -herpesvirus infection.

Singh R, Vangala R, Torne A, Bose D, Robertson E Front Microbiol. 2025; 15:1484455.

PMID: 39839102 PMC: 11747046. DOI: 10.3389/fmicb.2024.1484455.

Rewriting Viral Fate: Epigenetic and Transcriptional Dynamics in KSHV Infection.

Han C, Niu D, Lan K Viruses. 2025; 16(12.

PMID: 39772181 PMC: 11680275. DOI: 10.3390/v16121870.

EZH2 Inhibition by DS3201 Triggers the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle and Potentiates the Effects Induced by SAHA in Primary Effusion Lymphoma Cells.

Gonnella R, Collura F, Corrado V, Di Crosta M, Santarelli R, Cirone M Viruses. 2024; 16(9).

PMID: 39339966 PMC: 11437442. DOI: 10.3390/v16091490.

EZH2-Myc Hallmark in Oncovirus/Cytomegalovirus Infections and Cytomegalovirus' Resemblance to Oncoviruses.

El Baba R, Herbein G Cells. 2024; 13(6.

PMID: 38534385 PMC: 10970056. DOI: 10.3390/cells13060541.

Single-Cell RNA Sequencing Reveals the Role of Phosphorylation-Related Genes in Hepatocellular Carcinoma Stem Cells.

Yao F, Zhan Y, Li C, Lu Y, Chen J, Deng J Front Cell Dev Biol. 2022; 9:734287.

PMID: 35059393 PMC: 8763978. DOI: 10.3389/fcell.2021.734287.

References

Konrad A, Wies E, Thurau M, Marquardt G, Naschberger E, Hentschel S . A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol. 2009; 83(6):2563-74. PMC: 2648262. DOI: 10.1128/JVI.01512-08. View

Cheng A, Lau S, Chen Y, Kondo Y, Li M, Feng H . EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Res. 2011; 71(11):4028-39. DOI: 10.1158/0008-5472.CAN-10-3342. View

Carroll P, Brazeau E, Lagunoff M . Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology. 2004; 328(1):7-18. PMC: 3147029. DOI: 10.1016/j.virol.2004.07.008. View

Lu C, Han H, Mangala L, Ali-Fehmi R, Newton C, Ozbun L . Regulation of tumor angiogenesis by EZH2. Cancer Cell. 2010; 18(2):185-97. PMC: 2923653. DOI: 10.1016/j.ccr.2010.06.016. View

Iso T, Maeno T, Oike Y, Yamazaki M, Doi H, Arai M . Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem Biophys Res Commun. 2006; 341(3):708-14. DOI: 10.1016/j.bbrc.2006.01.020. View

Ye F, Blackbourn D, Mengel M, Xie J, Qian L, Greene W . Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J Virol. 2007; 81(8):3980-91. PMC: 1866109. DOI: 10.1128/JVI.02089-06. View

Smits M, Nilsson J, Mir S, Van der Stoop P, Hulleman E, Niers J . miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget. 2011; 1(8):710-20. PMC: 3124376. DOI: 10.18632/oncotarget.205. View

Scehnet J, Ley E, Krasnoperov V, Liu R, Manchanda P, Sjoberg E . The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 2008; 113(1):254-63. PMC: 2614637. DOI: 10.1182/blood-2008-02-140020. View

Sawamiphak S, Seidel S, Essmann C, Wilkinson G, Pitulescu M, Acker T . Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature. 2010; 465(7297):487-91. DOI: 10.1038/nature08995. View

10.

Paul T, Bies J, Small D, Wolff L . Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Blood. 2010; 115(15):3098-108. PMC: 2858468. DOI: 10.1182/blood-2009-07-233858. View

11.

Sivakumar R, Sharma-Walia N, Raghu H, Veettil M, Sadagopan S, Bottero V . Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications. J Virol. 2007; 82(4):1759-76. PMC: 2258737. DOI: 10.1128/JVI.00873-07. View

12.

Chang C, Yang J, Xia W, Chen C, Xie X, Chao C . EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. Cancer Cell. 2011; 19(1):86-100. PMC: 3041516. DOI: 10.1016/j.ccr.2010.10.035. View

13.

Wang H, Trotter M, Lagos D, Bourboulia D, Henderson S, Makinen T . Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet. 2004; 36(7):687-93. DOI: 10.1038/ng1384. View

14.

Gao S, Deng J, Zhou F . Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J Virol. 2003; 77(18):9738-49. PMC: 224610. DOI: 10.1128/jvi.77.18.9738-9749.2003. View

15.

Gunther T, Grundhoff A . The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 2010; 6(6):e1000935. PMC: 2880564. DOI: 10.1371/journal.ppat.1000935. View

16.

Shi B, Liang J, Yang X, Wang Y, Zhao Y, Wu H . Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol. 2007; 27(14):5105-19. PMC: 1951944. DOI: 10.1128/MCB.00162-07. View

17.

Trenkmann M, Brock M, Gay R, Kolling C, Speich R, Michel B . Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis. 2011; 70(8):1482-8. DOI: 10.1136/ard.2010.143040. View

18.

Salvucci O, Maric D, Economopoulou M, Sakakibara S, Merlin S, Follenzi A . EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood. 2009; 114(8):1707-16. PMC: 2731645. DOI: 10.1182/blood-2008-12-192294. View

19.

Sauvageau M, Sauvageau G . Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell. 2010; 7(3):299-313. PMC: 4959883. DOI: 10.1016/j.stem.2010.08.002. View

20.

Lin Y, Weisdorf D, Solovey A, Hebbel R . Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000; 105(1):71-7. PMC: 382587. DOI: 10.1172/JCI8071. View